Ancora Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12
| Closed | -$122 | – | 1787 |
|
|
2023
Q3 | $122 | Hold |
12
| – | – | ﹤0.01% | 1683 |
|
|
2023
Q2 | $90 | Hold |
12
| – | – | ﹤0.01% | 1716 |
|
|
2023
Q1 | $106 | Hold |
12
| – | – | ﹤0.01% | 1851 |
|
|
2022
Q4 | $0 | Hold |
12
| – | – | ﹤0.01% | 1895 |
|
|
2022
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 2117 |
|
|
2022
Q2 | $0 | Hold |
12
| – | – | ﹤0.01% | 2270 |
|
|
2022
Q1 | $0 | Hold |
12
| – | – | ﹤0.01% | 2473 |
|
|
2021
Q4 | $0 | Hold |
12
| – | – | ﹤0.01% | 2418 |
|
|
2021
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 2261 |
|
|
2021
Q2 | $0 | Hold |
12
| – | – | ﹤0.01% | 1974 |
|
|
2021
Q1 | $0 | Hold |
12
| – | – | ﹤0.01% | 1803 |
|
|
2020
Q4 | $0 | Hold |
12
| – | – | ﹤0.01% | 1499 |
|
|
2020
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 1405 |
|
|
2020
Q2 | $0 | Hold |
12
| – | – | ﹤0.01% | 1381 |
|
|
2020
Q1 | $0 | Sell |
12
-700
| -98% | – | ﹤0.01% | 1434 |
|
|
2019
Q4 | $7K | Buy |
+712
| New | +$7K | ﹤0.01% | 1203 |
|
|
2018
Q4 | – | Sell |
-2,037
| Closed | -$44K | – | 1125 |
|
|
2018
Q3 | $44K | Buy |
+2,037
| New | +$44K | ﹤0.01% | 917 |
|
|
2017
Q1 | – | Sell |
-5,975
| Closed | -$217K | – | 1030 |
|
|
2016
Q4 | $217K | Buy |
5,975
+600
| +11% | +$21.8K | 0.02% | 541 |
|
|
2016
Q3 | $247K | Hold |
5,375
| – | – | 0.03% | 440 |
|
|
2016
Q2 | $270K | Hold |
5,375
| – | – | 0.03% | 409 |
|
|
2016
Q1 | $288K | Hold |
5,375
| – | – | 0.04% | 389 |
|
|
2015
Q4 | $353K | Sell |
5,375
-53
| -1% | -$3.48K | 0.05% | 359 |
|
|
2015
Q3 | $306K | Hold |
5,428
| – | – | 0.04% | 383 |
|
|
2015
Q2 | $321K | Buy |
+5,428
| New | +$321K | 0.04% | 389 |
|
|
2015
Q1 | – | Sell |
-5,428
| Closed | -$312K | – | 375 |
|
|
2014
Q4 | $312K | Buy |
+5,428
| New | +$312K | 0.04% | 389 |
|
|
2014
Q1 | – | Sell |
-7,500
| Closed | -$301K | – | 461 |
|
|
2013
Q4 | $301K | Sell |
7,500
-500
| -6% | -$20.1K | 0.05% | 324 |
|
|
2013
Q3 | $302K | Sell |
8,000
-500
| -6% | -$18.9K | 0.05% | 310 |
|
|
2013
Q2 | $333K | Buy |
+8,500
| New | +$333K | 0.06% | 294 |
|